National Medicinal Cannabis Coalition
A coalition to advance cannabis-related regulatory changes
Based in DC
🤖
AI Overview
With $630K in lobbying spend across 17 quarterly filings, National Medicinal Cannabis Coalition is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2021 to 2024.
$630K
Total Spend
4
Years Active
1
Firms Hired
6
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $330K |
| 2022 | $300K |
| 2023 | $0 |
| 2024 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Banking, Law Enforcement
- •Safe Banking Act, 280E tax reform
- •Educate Members of Congress on Section 280e of the Internal Revenue Code and supported reforms to Section 280e; monitor COVID-19 relief proposals for cannabis-related tax provisions.
- •Support H.R. 1996, the SAFE Banking Act; monitor legislation to improve access to banking services for the cannabis industry.
- •Monitor pending legislation on cannabis reform.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.